Le Registre des lobbyistes
Amgen Canada Inc.
Objets poursuivis : Renseignements rétrospectifs : | - Health Canada re: Food and Drug Act, Regulations and Guidance- Health Canada re: Patented Medicines Notice of Compliance (NOC) Regulations- Health Canada re: Progressive Licensing Framework Policy- Health Canada re: Subsequent Entry Biologics Policy- Health Canada re: National Pharmaceutical Strategy- Health Canada re: Canadian Agency for Drugs and Technology in Health, Common Drug Review, Regulatory Approval, Health Canada- Food and Drug Act- Industry Canada re: Patent Act, Regulations and Guidance (including those on Patented Medicines Price Review Board)- Innovation Strategy Industry Canada re: "Mobilizing Science and Technology to Canada's Advantage" |
Objets poursuivis : Renseignements prospectifs : | - Health Canada re: Food and Drug Act, Regulations and Guidance- Health Canada re: Patented Medicines Notice of Compliance (NOC) Regulations- Health Canada re: Progressive Licensing Framework Policy- Health Canada re: Subsequent Entry Biologics Policy- Health Canada re: National Pharmaceutical Strategy- Health Canada re: Canadian Agency for Drugs and Technology in Health, Common Drug Review, Regulatory Approval, Health Canada- Food and Drug Act- Industry Canada re: Patent Act, Regulations and Guidance (including those on Patented Medicines Price Review Board)- Innovation Strategy Industry Canada re: "Mobilizing Science and Technology to Canada's Advantage" |
Catégories | Description |
---|---|
Politique ou programme | Health Canada re: Canadian Agency for Drugs and Technology in Health (Common Drug Review) |
Proposition législative | Health Canada re: Food and Drug Act |
Projet de loi ou résolution | Health Canada re: Food and Drug Act |
Politique ou programme | Health Canada re: Food and Drug Act Guidance |
Règlement | Health Canada re: Food and Drug Act Regulations |
Politique ou programme | Health Canada re: National Pharmaceutical Strategy |
Politique ou programme | Health Canada re: National Pharmaceutical Strategy, Regulatory Approval, Health Canada |
Politique ou programme | Health Canada re: Progressive Licensing Framework Policy |
Politique ou programme | Health Canada re: Subsequent Entry Biologics Policy |
Règlement | Health Canada re Patented Medicines (Notice of Compliance) Regulations |
Politique ou programme | Industry Canada re: "Mobilizing Science and Technology to Canada's Advantage". |
Proposition législative | Industry Canada re: Patent Act |
Projet de loi ou résolution | Industry Canada re: Patent Act |
Politique ou programme | Industry Canada re: Patent Act Guidance (including Patented Medicines Price Review Board Guidance) |
Règlement | Industry Canada re: Patent Act Regulations (including those on Patented Medicines Price Review Board) |
Politique ou programme | Innovation Strategy; |